Nevisense to Be Included in a Large Clinical Study Initiated by The Ronald O. Perelman Department of Dermatology Clinic at NYU Langone Health
The SpotCheck study will investigate the use of Nevisense as a point-of-care diagnostic tool to assist with skin cancer detection in a remote setting such as a non-specialist practice or pharmacy.
